一个恶性循环诱导器在胃病原:Helicobacter pylori的含义
Amiratabak Rajaei1, Pooya Mahdavi2, Rojan Chimehrad1
1Department of Molecular Biosciences, University of South Florida, Tampa, FL, USA.
Archives of microbiology
|January 12, 2026
概括
杆菌感染会产生BRCAness状态,损害DNA修复,导致基因组不稳定. 这与免疫系统的破坏一起,推动了胃癌的发展,提供了潜在的干预目标.
科学领域:
- 微生物学 微生物学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 杆菌是胃疾病的关键原因,包括癌症.
- 像CagA和VacA这样的毒性因素有助于H. pylori的病变.
- 驱动H. pylori相关致癌的综合机制尚未完全理解.
研究的目的:
- 审查H. pylori毒性因子在胃癌发生中的协调作用.
- 阐明H. pylori如何破坏DNA修复和宿主免疫反应.
- 为了确定预防H. pylori驱动的胃癌的潜在干预点.
主要方法:
- 文献综述整合了关于H. pylori毒性因素的证据.
- 对DNA损伤和修复障碍的分子机制的分析.
- 检查H. pylori对宿主免疫信号通路的影响.
主要成果:
- H. pylori 感染会诱导一种短暂的 BRCAness 状态,导致同源重组缺陷和基因组不稳定.
- 独立于CagA的通路和活性氧物种有助于DNA双链断裂.
- 感染破坏了瘤抑制路径 (p53) 和免疫信号 (NF-κB,JAK/STAT) 的调节,促进了免疫逃避.
结论:
- 杆菌毒性因子,DNA损伤和免疫调节的协调作用驱动胃癌发生.
- 了解这些综合机制可以揭示治疗干预的潜在目标.
- 破坏H. pylori感染及其相关途径可能会降低胃癌风险.
相关概念视频
Gastritis-II: Pathophysiology
1.2K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.2K
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
1.1K
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.1K
Peptic Ulcer Disease I: Introduction
725
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
725
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
1.1K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.1K
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
1.1K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.1K
Peptic Ulcer Disease II: Pathophysiology
1.9K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
1.9K


